CRISPR and siRNA manipulation of SOX17 in human pulmonary artery endothelial cells HPAEC
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
HPAEC were treated with either siRNA to SOX17 or CRISPR activating or inhibiting the promoter or an enhancer region associated with pulmonary hypertension and sequenced. Overall design: HPAEC were treated with either siRNA to SOX17 or CRISPR activating or inhibiting the promoter or an enhancer region associated with pulmonary hypertension and sequenced.
创建时间：
2023-07-12
相关数据集
暂无相关数据集
